|
G
|
Selenbp1
|
selenium binding protein 1
|
increases metabolic processing decreases metabolic processing
|
ISO
|
SELENBP1 protein results in increased metabolism of methylmercaptan SELENBP1 gene mutant form results in decreased metabolism of methylmercaptan
|
CTD |
PMID:29255262 |
|
NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
|
|
|
G
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1
|
multiple interactions
|
EXP
|
Dithiothreitol inhibits the reaction [methyl methanethiosulfonate inhibits the reaction [dexamethasone 21-methanesulfonate binds to NR3C1 protein]]; Dithiothreitol inhibits the reaction [methyl methanethiosulfonate inhibits the reaction [Dexamethasone binds to NR3C1 protein]]; methyl methanethiosulfonate inhibits the reaction [dexamethasone 21-methanesulfonate binds to NR3C1 protein]; methyl methanethiosulfonate inhibits the reaction [Dexamethasone binds to NR3C1 protein]; methyl methanethiosulfonate inhibits the reaction [NR3C1 protein binds to dexamethasone oxetanone]
|
CTD |
PMID:1597467 PMID:2226332 |
|
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
|
|
G
|
P2rx2
|
purinergic receptor P2X 2
|
multiple interactions
|
EXP
|
methyl methanethiosulfonate inhibits the reaction [Hydrogen Peroxide promotes the reaction [Adenosine Triphosphate results in increased activity of P2RX2 protein]]; methyl methanethiosulfonate inhibits the reaction [Mercury promotes the reaction [Adenosine Triphosphate results in increased activity of P2RX2 protein]]
|
CTD |
PMID:19793987 |
|
NCBI chr12:46,338,979...46,342,891
Ensembl chr12:46,339,549...46,342,891
|
|
G
|
Pgr
|
progesterone receptor
|
decreases activity
|
ISO
|
methyl methanethiosulfonate results in decreased activity of PGR protein
|
CTD |
PMID:9879984 |
|
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:6,072,673...6,131,344
|
|
|
G
|
Ap1s1
|
adaptor related protein complex 1 subunit sigma 1
|
decreases expression
|
ISO
|
Thioridazine results in decreased expression of AP1S1 mRNA
|
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr12:19,625,267...19,635,792
Ensembl chr12:19,625,332...19,756,713
|
|
G
|
Asah1
|
N-acylsphingosine amidohydrolase 1
|
increases expression
|
ISO
|
Thioridazine results in increased expression of ASAH1 mRNA
|
CTD |
PMID:17175557 |
|
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
|
|
G
|
Asns
|
asparagine synthetase (glutamine-hydrolyzing)
|
increases expression
|
ISO
|
Thioridazine results in increased expression of ASNS mRNA
|
CTD |
PMID:17175557 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G
|
Casp3
|
caspase 3
|
increases activity
|
ISO
|
Thioridazine results in increased activity of CASP3 protein
|
CTD |
PMID:21035837 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G
|
Ccnd1
|
cyclin D1
|
decreases expression
|
ISO
|
Thioridazine results in decreased expression of CCND1 protein
|
CTD |
PMID:21035837 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
|
|
G
|
Cdc25a
|
cell division cycle 25A
|
increases phosphorylation
|
ISO
|
Thioridazine results in increased phosphorylation of CDC25A protein
|
CTD |
PMID:21035837 |
|
NCBI chr 8:118,742,824...118,761,190
Ensembl chr 8:109,864,478...109,882,701
|
|
G
|
Cdk4
|
cyclin-dependent kinase 4
|
decreases expression
|
ISO
|
Thioridazine results in decreased expression of CDK4 protein
|
CTD |
PMID:21035837 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:62,883,105...62,942,403
|
|
G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
increases expression
|
ISO
|
Thioridazine results in increased expression of CDKN1A protein
|
CTD |
PMID:21035837 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
|
|
G
|
Cdkn2a
|
cyclin-dependent kinase inhibitor 2A
|
increases expression
|
ISO
|
Thioridazine results in increased expression of CDKN2A protein
|
CTD |
PMID:21035837 |
|
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:103,984,949...104,003,149
|
|
G
|
Ces1d
|
carboxylesterase 1D
|
multiple interactions
|
ISO
|
Thioridazine inhibits the reaction [CES1 protein results in increased hydrolysis of 4-nitrophenyl acetate]; Thioridazine inhibits the reaction [CES1 protein results in increased hydrolysis of Methylphenidate]
|
CTD |
PMID:20097249 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G
|
Crh
|
corticotropin releasing hormone
|
decreases expression
|
ISO
|
Thioridazine results in decreased expression of CRH mRNA
|
CTD |
PMID:16205782 |
|
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
multiple interactions
|
ISO
|
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine; CYP1A2 protein results in increased metabolism of and results in increased activity of Thioridazine
|
CTD |
PMID:19482014 PMID:23397584 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G
|
Cyp2c6
|
cytochrome P450, family 2, subfamily C, polypeptide 6
|
multiple interactions decreases activity
|
ISO
|
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine Thioridazine results in decreased activity of CYP2C19 protein
|
CTD |
PMID:15135088 PMID:23397584 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G
|
Cyp2d4
|
cytochrome P450, family 2, subfamily d, polypeptide 4
|
multiple interactions
|
ISO
|
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine; CYP2D6 protein results in increased metabolism of and results in increased activity of Thioridazine
|
CTD |
PMID:19482014 PMID:23397584 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
decreases activity
|
ISO
|
Thioridazine results in decreased activity of CYP2E1 protein
|
CTD |
PMID:15135088 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
multiple interactions decreases activity
|
ISO
|
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine Thioridazine results in decreased activity of CYP3A4 protein
|
CTD |
PMID:15135088 PMID:23397584 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G
|
Depp1
|
DEPP autophagy regulator 1
|
increases expression
|
ISO
|
Thioridazine results in increased expression of DEPP1 mRNA
|
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
|
|
G
|
Eif4ebp1
|
eukaryotic translation initiation factor 4E binding protein 1
|
decreases phosphorylation
|
ISO
|
Thioridazine results in decreased phosphorylation of EIF4EBP1 protein
|
CTD |
PMID:21035837 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G
|
Fabp1
|
fatty acid binding protein 1
|
increases expression
|
ISO
|
Thioridazine results in increased expression of FABP1 mRNA
|
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
|
|
G
|
Fndc4
|
fibronectin type III domain containing 4
|
increases expression
|
ISO
|
Thioridazine results in increased expression of FNDC4 mRNA
|
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr 6:25,077,155...25,080,812
Ensembl chr 6:25,077,349...25,080,675
|
|
G
|
Gdpd3
|
glycerophosphodiester phosphodiesterase domain containing 3
|
increases expression
|
ISO
|
Thioridazine results in increased expression of GDPD3 mRNA
|
CTD |
PMID:17175557 |
|
NCBI chr 1:181,373,505...181,383,063
Ensembl chr 1:181,366,626...181,383,063
|
|
G
|
Hpn
|
hepsin
|
increases expression
|
ISO
|
Thioridazine results in increased expression of HPN mRNA
|
CTD |
PMID:15342952 |
|
NCBI chr 1:86,337,085...86,352,785
Ensembl chr 1:86,337,087...86,352,811
|
|
G
|
Inhbe
|
inhibin subunit beta E
|
increases expression
|
ISO
|
Thioridazine results in increased expression of INHBE mRNA
|
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
|
|
G
|
Kcnh2
|
potassium voltage-gated channel subfamily H member 2
|
multiple interactions decreases activity
|
ISO
|
Thioridazine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] Thioridazine results in decreased activity of KCNH2 protein
|
CTD |
PMID:15671647 PMID:16278312 PMID:21158687 PMID:24052561 |
|
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:10,826,928...10,859,008
|
|
G
|
Lss
|
lanosterol synthase
|
increases expression
|
ISO
|
Thioridazine results in increased expression of LSS mRNA
|
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
|
|
G
|
Nr0b2
|
nuclear receptor subfamily 0, group B, member 2
|
increases expression
|
ISO
|
Thioridazine results in increased expression of NR0B2 mRNA
|
CTD |
PMID:17175557 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G
|
Nupr1
|
nuclear protein 1, transcriptional regulator
|
increases expression
|
ISO
|
Thioridazine results in increased expression of NUPR1 mRNA
|
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
|
|
G
|
Phyh
|
phytanoyl-CoA 2-hydroxylase
|
increases expression
|
ISO
|
Thioridazine results in increased expression of PHYH mRNA
|
CTD |
PMID:15342952 |
|
NCBI chr17:73,329,461...73,346,359
Ensembl chr17:73,329,082...73,346,409
|
|
G
|
Prl
|
prolactin
|
increases expression
|
ISO
|
Thioridazine results in increased expression of PRL protein
|
CTD |
PMID:4065553 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G
|
Serpina3n
|
serpin family A member 3N
|
increases expression
|
ISO
|
Thioridazine results in increased expression of SERPINA3 mRNA
|
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
|
|
G
|
Slc22a2
|
solute carrier family 22 member 2
|
multiple interactions
|
ISO
|
Thioridazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
|
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G
|
Slc2a3
|
solute carrier family 2 member 3
|
decreases expression
|
ISO
|
Thioridazine results in decreased expression of SLC2A3 mRNA
|
CTD |
PMID:15342952 |
|
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
|
|
G
|
Tagln
|
transgelin
|
decreases expression
|
ISO
|
Thioridazine results in decreased expression of TAGLN mRNA
|
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
|
|
G
|
Tp53
|
tumor protein p53
|
affects activity
|
ISO
|
Thioridazine affects the activity of TP53 protein
|
CTD |
PMID:35435491 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
|
|
G
|
Wipi1
|
WD repeat domain, phosphoinositide interacting 1
|
increases expression
|
ISO
|
Thioridazine results in increased expression of WIPI1 mRNA
|
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr10:94,542,946...94,580,174
Ensembl chr10:94,542,946...94,579,846
|
|